- Home
- ETON vs CYRX Comparison
ETON vs CYRX Comparison
Compare ETON & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | CYRX |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.7M | 419.3M |
| IPO Year | 2018 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ETON | CYRX |
|---|---|---|
| Price | $27.12 | $9.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $39.33 | $12.94 |
| AVG Volume (30 Days) | ★ 468.4K | 406.1K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | $79,950,000.00 | ★ $176,177,000.00 |
| Revenue This Year | $40.90 | $11.06 |
| Revenue Next Year | $47.23 | $8.45 |
| P/E Ratio | ★ N/A | $6.89 |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.09 | $5.21 |
| 52 Week High | $27.19 | $11.45 |
Technical Indicators
Market Signals| Indicator | ETON | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 72.12 | 70.69 |
| Support Level | $16.38 | $9.18 |
| Resistance Level | N/A | $10.23 |
| Average True Range (ATR) | 1.28 | 0.42 |
| MACD | 0.08 | 0.19 |
| Stochastic Oscillator | 90.65 | 88.01 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.